Global efforts to expand rubella vaccination are delivering significant results, with cases of congenital rubella syndrome (CRS)—a serious condition that causes birth defects in babies—falling dramatically since 2012. According to global health data, the number of countries including rubella vaccination in routine immunization schedules increased significantly between 2012 and 2022, while worldwide infant vaccination coverage also improved. The decline in congenital rubella syndrome highlights the powerful impact of vaccination programmes. Health experts emphasize that continued investment in vaccination systems, disease surveillance and community outreach will be necessary to achieve global rubella elimination goals. With sustained commitment and equitable vaccine access, countries can continue moving closer to a future where congenital rubella syndrome becomes a rare and preventable condition.